Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
World Bank debars fraudulent Vietnamese vendor
What happened: On August 18, 2021, the World Bank announced that it had debarred a third-party vendor, Vietnamese company Newstech Trading and Investment...